Novus Surgical is a medical distribution company headquartered in Sydney with representation throughout Australia. Our sole focus is bringing XPERIENCE to the Australian market. We are passionate about working with healthcare professionals to improve patient outcomes.

Gary Mitchell

A high performing senior executive with significant experience as Managing Director and Vice President in the medical solutions, medical devices and medical distribution sectors. A strong Sales and Marketing leader with an excellent track record.

A highly customer focused leader.

Responsible for leading the Orthopedic, Spine, Cardiovascular/Interventional, Gastroenterology, Plastic/Reconstructive Surgery divisions, Professional Education, Advanced Skin Technologies and Advanced Skin Technologies International and creating DT Intelligent Health division. At BSC endoscopy, urology, and electrophysiology over a seven year period.

State Representatives

We have representatives in all states in Australia with many years of experience across multiple disciplines in theatre.

NSW:

  • Evan at Aeson Medical - E: evan@aesonmedical.com M: 0474 07 552
  • Ashley at Active Surgical - E: ashley@acticesurgical.com.au M: 0437 722 310
  • Jeremy at Universal Surgical - E: jeremy@universal-surgical.com M: 0428 756 956
  • Dan at Range Orthopaedics - E: dan@rangeortho.com M: 0404 860 792

VIC:

  • Mark at Versant Surgical - E: mark@versantsurgical.com.au M: 0493 492 582

SA:

  • Kieran at KRLP - E: kieranryan2010@gmail.com M: 0417 492 179

TAS:

  • Brenton at Technomedical - E: brenton@technomedical.com.au M: 0400 997 550

WA:

  • Mikhaela at Fusion Surgical - E: mikhaela@fusionsurgical.com.au M: 0418 519 414

QLD:

  • Sacha at MediSolutions - E: sacha@medisolutionsaustralia.com
  • Scott at JPG Health - E: scott.lavery92@yahoo.com M: 0456 787 471

Our Industry Partner – Next Science Technologies Pty Ltd

Next Science™ pioneers innovative, proprietary technologies to address the problem of biofilm. As a partner of Next Science, Novus Surgical delivers break-through solutions that see beyond the current limits imposed by powerful bacterial colonies.

We offer a new solution to the biofilm problem with a proprietary, non-toxic technology that disrupts the biofilm’s extracellular polymeric substance (EPS) matrix and, unlike competitors, offers no known opportunity for bacterial resistance.

Clinical studies and field evaluations have shown the products advance healing, reduce the number of bacteria present, and regardless of setting, help to prevent the growth of further biofilm structures.

We are shifting the paradigm of biofilm eradication in open surgery including

· Arthroplasty
· Spine and Neurosurgery
· Plastics and Reconstructive Surgery
· Orthopedic Trauma